Stormram 4: An MR Safe Robotic System for Breast Biopsy.

Autor: Groenhuis V; Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands. v.groenhuis@utwente.nl., Siepel FJ; Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands., Veltman J; Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands., van Zandwijk JK; Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands., Stramigioli S; Department of Robotics and Mechatronics, University of Twente, att. Vincent Groenhuis, Room CR-3.526, Postbus 217, 7500AE, Enschede, The Netherlands.
Jazyk: angličtina
Zdroj: Annals of biomedical engineering [Ann Biomed Eng] 2018 Oct; Vol. 46 (10), pp. 1686-1696. Date of Electronic Publication: 2018 May 21.
DOI: 10.1007/s10439-018-2051-5
Abstrakt: Suspicious lesions in the breast that are only visible on magnetic resonance imaging (MRI) need to be biopsied under MR guidance with high accuracy and efficiency for accurate diagnosis. The aim of this study is to present a novel robotic system, the Stormram 4, and to perform preclinical tests in an MRI environment. Excluding racks and needle, its dimensions are 72 × 51 × 40 mm. The Stormram 4 is driven by two linear and two curved pneumatic stepper motors. The linear motor is capable of exerting 63 N of force at a pressure of 0.65 MPa. In an MRI environment the maximum observed stepping frequency is 30 Hz (unloaded), or 8 Hz when full force is needed. The Stormram 4's mean positioning error is 0.73 ± 0.47 mm in free air, and 1.29 ± 0.59 mm when targeting breast phantoms in MRI. Excluding the off-the-shelf needle, the robot is inherently MR safe. The robot is able to accurately target lesions under MRI guidance, reducing tissue damage and risk of false negatives. These results are promising for clinical experiments, improving the quality of healthcare in the field of MRI-guided breast biopsies.
Databáze: MEDLINE